Mounjaro – Tirzepatide
Tirzepadtide also known as Mounjaro is a GLP1/GIP agonist. Other medications such as semaglutide, liraglutide, are also known as GLP-1 agonists. Both types of drugs work in the same way and minic hut hormomes released by the body after eating, telling the brain you are full and slowing down the time it takes for the stomach to empty.
New community based weight management services are being developed across the Black Country to support safe and effective access to Mounjaro, a medication that can help with weight loss and other related health conditions. These will be available via primary care from Monday 1st September 2025.
Mounjaro will not be accessible to everyone who wishes to use it. People with the highest health risks and who meet the clinical criteria will be prioritised.
More information here.
Please do not contact your GP practice about Mounjaro at this time. If you are eligible you will be contacted by your practice.
Thank you
The Saddlers Health Centre